Literature DB >> 33811691

E-selectin negatively regulates polymorphonuclear neutrophil transmigration through altered endothelial junction integrity.

Dandan Huang1,2, Qihan Ding1,2, Shenbao Chen1,2, Shouqin Lü1,2, Yan Zhang1,2, Mian Long1,2,3.   

Abstract

Transendothelial migration (TEM) of neutrophils under blood flow is critical in the inflammatory cascade. However, the role of endothelial plasticity in this process is not fully understood. Therefore, we used an in vitro model to test the dynamics of human polymorphonuclear neutrophil (PMN) TEM across lipopolysaccharide-treated human umbilical vein endothelial cell (HUVEC) monolayers. Interestingly, shRNA-E-selectin knockdown in HUVECs destabilized endothelial junctional integrity by reducing actin branching and increasing stress fiber at cell-cell junctions. This process is accomplished by downregulating the activation of cortactin and Arp2/3, which in turn alters the adhesive function of VE-cadherin, enhancing PMN transmigration. Meanwhile, redundant P-selectins possess overlapping functions in E-selectin-mediated neutrophil adhesion, and transmigration. These results demonstrate, to our knowledge, for the first time, that E-selectins negatively regulate neutrophil transmigration through alterations in endothelial plasticity. Furthermore, it improves our understanding of the mechanisms underlying actin remodeling, and junctional integrity, in endothelial cells mediating leukocyte TEM.
© 2021 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  E-selectin; cytoskeletal remodeling; endothelial integrity; neutrophil; transmigration

Mesh:

Substances:

Year:  2021        PMID: 33811691     DOI: 10.1096/fj.202000662RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  1 in total

1.  AQP5-1364A/C Polymorphism Affects AQP5 Promoter Methylation.

Authors:  Katharina Rump; Theresa Spellenberg; Alexander von Busch; Alexander Wolf; Dominik Ziehe; Patrick Thon; Tim Rahmel; Michael Adamzik; Björn Koos; Matthias Unterberg
Journal:  Int J Mol Sci       Date:  2022-10-05       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.